Skip to main
MYO
MYO logo

Myomo (MYO) Stock Forecast & Price Target

Myomo (MYO) Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Myomo Inc has reported impressive financial growth, with record total revenues of $12.1 million for the quarter, marking a 154% year-over-year increase and surpassing consensus estimates. The company's strong quarterly performance is attributed to a higher average selling price driven by increased Medicare patient volume, alongside a 106% year-over-year rise in total revenue units. With a robust gross margin of 71% and a growing reimbursement pipeline of 1,389 units, Myomo is poised for continued revenue increases, projecting total revenue of $52.3 million in 2025, reflecting a significant upward revision from earlier estimates.

Bears say

Myomo Inc's financial outlook presents several challenges, notably a decrease in backlog for insurance-authorized orders, which declined from 316 to 272, indicating potential difficulties in future revenue generation. Additionally, the company faces significant risks related to its balance sheet and liquidity, regulatory approvals, competition, and reimbursement challenges, all of which could impede its ability to commercialize products effectively. Although Myomo reported a smaller net loss than expected at $0.01 per share as opposed to the consensus estimate of $0.02, the underlying risks and concerns overshadow growth prospects, contributing to a negative outlook on the stock.

Myomo (MYO) has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Myomo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Myomo (MYO) Forecast

Analysts have given Myomo (MYO) a Strong Buy based on their latest research and market trends.

According to 8 analysts, Myomo (MYO) has a Strong Buy consensus rating as of Aug 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.52, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.52, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Myomo (MYO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.